Company profile: PackGene
1.1 - Company Overview
Company description
- Provider of CRO/CDMO services for gene and cell therapy, specializing in AAV vectors, mRNA, plasmid DNA, and lentiviral solutions. Offerings include AAV vector design and construction; small- to large-scale AAV production up to GMP; π-Icosa serotype screening; Express Gene-to-AAV from synthesis to packaging; and on-demand gene editing mRNAs (e.g., Cas9). Supports discovery, preclinical, and trials.
Products and services
- AAV Vector Design & Construction: PackGene architects end-to-end AAV vector design and construction for genetic payload delivery, supporting applications from discovery science to clinical practices
- AAV Services: PackGene delivers small- to large-scale AAV production suitable for in vitro discovery work, in vivo experiments, and clinical trials through GMP-grade manufacture
- Express Gene-to-AAV Service: This streamlined pipeline spans gene synthesis, virus packaging, and analytical tests, delivering finished AAV products in as fast as 4 weeks
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PackGene
Jubilee Clinical Research
HQ: United States
Website
- Description: Provider of clinical research across diverse indications, including new antibiotic developments and the latest diabetic therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jubilee Clinical Research company profile →
Adams Clinical
HQ: United States
Website
- Description: Provider of late-phase psychiatric and neurologic clinical trials in Massachusetts, conducting double-blind, randomized, placebo-controlled studies on investigational drugs. Also runs open-label depression monitoring (TRAIT-MDD-107) and Alzheimer's studies: ABBV-552 (M23-515 AbroAD) for mild AD and remternetug (J1G-MC-LAKC TRAILRUNNER-ALZ-1) for early symptomatic AD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adams Clinical company profile →
BioCentriq
HQ: United States
Website
- Description: Provider of cell and gene therapy development and GMP manufacturing services, including process development (upstream and downstream), clinical-grade drug product manufacturing across all trial phases, MS&T technical and regulatory support, quality assurance for cGMP compliance, workforce development training, and the LEAP Advanced Therapy Platform to accelerate transition from contract to clinic.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioCentriq company profile →
Intrinsic Imaging
HQ: United States
Website
- Description: Provider of full-service medical imaging core lab solutions supporting Phase I-IV Clinical Trials and Class I-III Medical Device Trials. Services include study and site management across 4,000 imaging sites in 75 countries, optimized Imaging Charters, ISO-certified image acquisition protocols, and clinical trial imaging solutions for pharmaceutical, biotechnology, and medical device companies, including AI/CAD clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intrinsic Imaging company profile →
Siegfried
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing for active pharmaceutical ingredients and drug products, including intermediates and controlled substances. Services span process development and optimization, formulation and pilot-scale production, registration support, and packaging and logistics for tablets, capsules, sterile vials, ampoules, cartridges, and ointments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siegfried company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PackGene
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PackGene
2.2 - Growth funds investing in similar companies to PackGene
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PackGene
4.2 - Public trading comparable groups for PackGene
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →